← 產業報告目錄
Cancer Spit Test Device Industry Research Report 2026
出版商 APO Research產業別 Medical Devices出版日期 2026-07-04頁數 134報告編號 APO-a666e85099
授權報價
| Single User | $2,950 USD |
| Multi User | $4,430 USD |
| Enterprise | $5,900 USD |
報告摘要
The global Cancer Spit Test Device market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Cancer Spit Test Device is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Cancer Spit Test Device is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
The Asia Pacific market for Cancer Spit Test Device is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Cancer Spit Test Device include Thermo Fisher Scientific, Siemens Healthineers, Sarstedt, Salimetrics, Roche Holding AG, Qiagen, PeriRx, Oasis Diagnostics Corporation and Miraclean Technology Co.,Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Cancer Spit Test Device market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Cancer Spit Test Device Market by Company
Thermo Fisher Scientific
Siemens Healthineers
Sarstedt
Salimetrics
Roche Holding AG
Qiagen
PeriRx
Oasis Diagnostics Corporation
Miraclean Technology Co.,Ltd.
Illumina
DNA Genotek Inc.
Color Health Inc
Canvax
BioMerieux
Biocartis Group
BD
Agilent Technologies
Abbott Laboratories
Cancer Spit Test Device Segment by Type
Passive Drool Collection Methods
Oral Swab Collection Methods
Cancer Spit Test Device Segment by Application
Cancer Research Institutes
Hospitals
Diagnostic Laboratories
Oncology Speciality Clinics
Others
Cancer Spit Test Device Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cancer Spit Test Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cancer Spit Test Device and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cancer Spit Test Device.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Cancer Spit Test Device manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Cancer Spit Test Device by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Cancer Spit Test Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
目錄 Table of Contents
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Cancer Spit Test Device Market Size (2021-2032)
2.2.2 Global Cancer Spit Test Device Sales (2021-2032)
2.2.3 Global Cancer Spit Test Device Market Average Price (2021-2032)
2.3 Cancer Spit Test Device by Type
2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
2.3.2 Passive Drool Collection Methods
2.3.3 Oral Swab Collection Methods
2.4 Cancer Spit Test Device by Application
2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
2.4.2 Cancer Research Institutes
2.4.3 Hospitals
2.4.4 Diagnostic Laboratories
2.4.5 Oncology Speciality Clinics
2.4.6 Others
3 Market Competitive Landscape by Manufacturers
3.1 Global Cancer Spit Test Device Market Competitive Situation by Manufacturers (2021 Versus 2025)
3.2 Global Cancer Spit Test Device Sales (k units) of Manufacturers (2021-2026)
3.3 Global Cancer Spit Test Device Revenue of Manufacturers (2021-2026)
3.4 Global Cancer Spit Test Device Average Price by Manufacturers (2021-2026)
3.5 Global Cancer Spit Test Device Industry Ranking, 2024 VS 2025 VS 2026
3.6 Global Manufacturers of Cancer Spit Test Device, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Cancer Spit Test Device, Product Type & Application
3.8 Global Manufacturers of Cancer Spit Test Device, Established Date
3.9 Global Cancer Spit Test Device Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Thermo Fisher Scientific
4.1.1 Thermo Fisher Scientific Company Information
4.1.2 Thermo Fisher Scientific Business Overview
4.1.3 Thermo Fisher Scientific Cancer Spit Test Device Sales, Revenue and Gross Margin (2021-2026)
4.1.4 Thermo Fisher Scientific Cancer Spit Test Device Product Portfolio
4.1.5 Thermo Fisher Scientific Recent Developments
4.2 Siemens Healthineers
4.2.1 Siemens Healthineers Company Information
4.2.2 Siemens Healthineers Business Overview
4.2.3 Siemens Healthineers Cancer Spit Test Device Sales, Revenue and Gross Margin (2021-2026)
4.2.4 Siemens Healthineers Cancer Spit Test Device Product Portfolio
4.2.5 Siemens Healthineers Recent Developments
4.3 Sarstedt
4.3.1 Sarstedt Company Information
4.3.2 Sarstedt Business Overview
4.3.3 Sarstedt Cancer Spit Test Device Sales, Revenue and Gross Margin (2021-2026)
4.3.4 Sarstedt Cancer Spit Test Device Product Portfolio
4.3.5 Sarstedt Recent Developments
4.4 Salimetrics
4.4.1 Salimetrics Company Information
4.4.2 Salimetrics Business Overview
4.4.3 Salimetrics Cancer Spit Test Device Sales, Revenue and Gross Margin (2021-2026)
4.4.4 Salimetrics Cancer Spit Test Device Product Portfolio
4.4.5 Salimetrics Recent Developments
4.5 Roche Holding AG
4.5.1 Roche Holding AG Company Information
4.5.2 Roche Holding AG Business Overview
4.5.3 Roche Holding AG Cancer Spit Test Device Sales, Revenue and Gross Margin (2021-2026)
4.5.4 Roche Holding AG Cancer Spit Test Device Product Portfolio
4.5.5 Roche Holding AG Recent Developments
4.6 Qiagen
4.6.1 Qiagen Company Information
4.6.2 Qiagen Business Overview
4.6.3 Qiagen Cancer Spit Test Device Sales, Revenue and Gross Margin (2021-2026)
4.6.4 Qiagen Cancer Spit Test Device Product Portfolio
4.6.5 Qiagen Recent Developments
4.7 PeriRx
4.7.1 PeriRx Company Information
4.7.2 PeriRx Business Overview
4.7.3 PeriRx Cancer Spit Test Device Sales, Revenue and Gross Margin (2021-2026)
4.7.4 PeriRx Cancer Spit Test Device Product Portfolio
4.7.5 PeriRx Recent Developments
4.8 Oasis Diagnostics Corporation
4.8.1 Oasis Diagnostics Corporation Company Information
4.8.2 Oasis Diagnostics Corporation Business Overview
4.8.3 Oasis Diagnostics Corporation Cancer Spit Test Device Sales, Revenue and Gross Margin (2021-2026)
4.8.4 Oasis Diagnostics Corporation Cancer Spit Test Device Product Portfolio
4.8.5 Oasis Diagnostics Corporation Recent Developments
4.9 Miraclean Technology Co.,Ltd.
4.9.1 Miraclean Technology Co.,Ltd. Company Information
4.9.2 Miraclean Technology Co.,Ltd. Business Overview
4.9.3 Miraclean Technology Co.,Ltd. Cancer Spit Test Device Sales, Revenue and Gross Margin (2021-2026)
4.9.4 Miraclean Technology Co.,Ltd. Cancer Spit Test Device Product Portfolio
4.9.5 Miraclean Technology Co.,Ltd. Recent Developments
4.10 Illumina
4.10.1 Illumina Company Information
4.10.2 Illumina Business Overview
4.10.3 Illumina Cancer Spit Test Device Sales, Revenue and Gross Margin (2021-2026)
4.10.4 Illumina Cancer Spit Test Device Product Portfolio
4.10.5 Illumina Recent Developments
4.11 DNA Genotek Inc.
4.11.1 DNA Genotek Inc. Company Information
4.11.2 DNA Genotek Inc. Business Overview
4.11.3 DNA Genotek Inc. Cancer Spit Test Device Sales, Revenue and Gross Margin (2021-2026)
4.11.4 DNA Genotek Inc. Cancer Spit Test Device Product Portfolio
4.11.5 DNA Genotek Inc. Recent Developments
4.12 Color Health Inc
4.12.1 Color Health Inc Company Information
4.12.2 Color Health Inc Business Overview
4.12.3 Color Health Inc Cancer Spit Test Device Sales, Revenue and Gross Margin (2021-2026)
4.12.4 Color Health Inc Cancer Spit Test Device Product Portfolio
4.12.5 Color Health Inc Recent Developments
4.13 Canvax
4.13.1 Canvax Company Information
4.13.2 Canvax Business Overview
4.13.3 Canvax Cancer Spit Test Device Sales, Revenue and Gross Margin (2021-2026)
4.13.4 Canvax Cancer Spit Test Device Product Portfolio
4.13.5 Canvax Recent Developments
4.14 BioMerieux
4.14.1 BioMerieux Company Information
4.14.2 BioMerieux Business Overview
4.14.3 BioMerieux Cancer Spit Test Device Sales, Revenue and Gross Margin (2021-2026)
4.14.4 BioMerieux Cancer Spit Test Device Product Portfolio
4.14.5 BioMerieux Recent Developments
4.15 Biocartis Group
4.15.1 Biocartis Group Company Information
4.15.2 Biocartis Group Business Overview
4.15.3 Biocartis Group Cancer Spit Test Device Sales, Revenue and Gross Margin (2021-2026)
4.15.4 Biocartis Group Cancer Spit Test Device Product Portfolio
4.15.5 Biocartis Group Recent Developments
4.16 BD
4.16.1 BD Company Information
4.16.2 BD Business Overview
4.16.3 BD Cancer Spit Test Device Sales, Revenue and Gross Margin (2021-2026)
4.16.4 BD Cancer Spit Test Device Product Portfolio
4.16.5 BD Recent Developments
4.17 Agilent Technologies
4.17.1 Agilent Technologies Company Information
4.17.2 Agilent Technologies Business Overview
4.17.3 Agilent Technologies Cancer Spit Test Device Sales, Revenue and Gross Margin (2021-2026)
4.17.4 Agilent Technologies Cancer Spit Test Device Product Portfolio
4.17.5 Agilent Technologies Recent Developments
4.18 Abbott Laboratories
4.18.1 Abbott Laboratories Company Information
4.18.2 Abbott Laboratories Business Overview
4.18.3 Abbott Laboratories Cancer Spit Test Device Sales, Revenue and Gross Margin (2021-2026)
4.18.4 Abbott Laboratories Cancer Spit Test Device Product Portfolio
4.18.5 Abbott Laboratories Recent Developments
5 Global Cancer Spit Test Device Market Scenario by Region
5.1 Global Cancer Spit Test Device Market Size by Region: 2021 VS 2025 VS 2032
5.2 Global Cancer Spit Test Device Sales by Region: 2021-2032
5.2.1 Global Cancer Spit Test Device Sales by Region: 2021-2026
5.2.2 Global Cancer Spit Test Device Sales by Region: 2027-2032
5.3 Global Cancer Spit Test Device Revenue by Region: 2021-2032
5.3.1 Global Cancer Spit Test Device Revenue by Region: 2021-2026
5.3.2 Global Cancer Spit Test Device Revenue by Region: 2027-2032
5.4 North America Cancer Spit Test Device Market Facts & Figures by Country
5.4.1 North America Cancer Spit Test Device Market Size by Country: 2021 VS 2025 VS 2032
5.4.2 North America Cancer Spit Test Device Sales by Country (2021-2032)
5.4.3 North America Cancer Spit Test Device Revenue by Country (2021-2032)
5.4.4 United States
5.4.5 Canada
5.4.6 Mexico
5.5 Europe Cancer Spit Test Device Market Facts & Figures by Country
5.5.1 Europe Cancer Spit Test Device Market Size by Country: 2021 VS 2025 VS 2032
5.5.2 Europe Cancer Spit Test Device Sales by Country (2021-2032)
5.5.3 Europe Cancer Spit Test Device Revenue by Country (2021-2032)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.5.9 Spain
5.5.10 Netherlands
5.5.11 Switzerland
5.5.12 Sweden
5.5.13 Poland
5.6 Asia Pacific Cancer Spit Test Device Market Facts & Figures by Country
5.6.1 Asia Pacific Cancer Spit Test Device Market Size by Country: 2021 VS 2025 VS 2032
5.6.2 Asia Pacific Cancer Spit Test Device Sales by Country (2021-2032)
5.6.3 Asia Pacific Cancer Spit Test Device Revenue by Country (2021-2032)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 Taiwan
5.6.10 Southeast Asia
5.7 South America Cancer Spit Test Device Market Facts & Figures by Country
5.7.1 South America Cancer Spit Test Device Market Size by Country: 2021 VS 2025 VS 2032
5.7.2 South America Cancer Spit Test Device Sales by Country (2021-2032)
5.7.3 South America Cancer Spit Test Device Revenue by Country (2021-2032)
5.7.4 Brazil
5.7.5 Argentina
5.7.6 Chile
5.8 Middle East and Africa Cancer Spit Test Device Market Facts & Figures by Country
5.8.1 Middle East and Africa Cancer Spit Test Device Market Size by Country: 2021 VS 2025 VS 2032
5.8.2 Middle East and Africa Cancer Spit Test Device Sales by Country (2021-2032)
5.8.3 Middle East and Africa Cancer Spit Test Device Revenue by Country (2021-2032)
5.8.4 Egypt
5.8.5 South Africa
5.8.6 Israel
5.8.7 Türkiye
5.8.8 GCC Countries
6 Segment by Type
6.1 Global Cancer Spit Test Device Sales by Type (2021-2032)
6.1.1 Global Cancer Spit Test Device Sales by Type (2021-2032) & (k units)
6.1.2 Global Cancer Spit Test Device Sales Market Share by Type (2021-2032)
6.2 Global Cancer Spit Test Device Revenue by Type (2021-2032)
6.2.1 Global Cancer Spit Test Device Sales by Type (2021-2032) & (US$ Million)
6.2.2 Global Cancer Spit Test Device Revenue Market Share by Type (2021-2032)
6.3 Global Cancer Spit Test Device Price by Type (2021-2032)
7 Segment by Application
7.1 Global Cancer Spit Test Device Sales by Application (2021-2032)
7.1.1 Global Cancer Spit Test Device Sales by Application (2021-2032) & (k units)
7.1.2 Global Cancer Spit Test Device Sales Market Share by Application (2021-2032)
7.2 Global Cancer Spit Test Device Revenue by Application (2021-2032)
7.2.1 Global Cancer Spit Test Device Sales by Application (2021-2032) & (US$ Million)
7.2.2 Global Cancer Spit Test Device Revenue Market Share by Application (2021-2032)
7.3 Global Cancer Spit Test Device Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Cancer Spit Test Device Value Chain Analysis
8.1.1 Cancer Spit Test Device Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Cancer Spit Test Device Production Mode & Process
8.2 Cancer Spit Test Device Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Cancer Spit Test Device Distributors
8.2.3 Cancer Spit Test Device Customers
9 Global Cancer Spit Test Device Analyzing Market Dynamics
9.1 Cancer Spit Test Device Industry Trends
9.2 Cancer Spit Test Device Industry Drivers
9.3 Cancer Spit Test Device Industry Opportunities and Challenges
9.4 Cancer Spit Test Device Industry Restraints
10 Report Conclusion
11 Disclaimer
圖表清單 List of Tables & Figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Cancer Spit Test Device Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025)
Table 6. Global Cancer Spit Test Device Sales (k units) of Manufacturers (2021-2026)
Table 7. Global Cancer Spit Test Device Sales Market Share by Manufacturers (2021-2026)
Table 8. Global Cancer Spit Test Device Revenue of Manufacturers (2021-2026)
Table 9. Global Cancer Spit Test Device Revenue Share by Manufacturers (2021-2026)
Table 10. Global Market Cancer Spit Test Device Average Price (USD/unit) of Manufacturers (2021-2026)
Table 11. Global Cancer Spit Test Device Industry Ranking, 2024 VS 2025 VS 2026
Table 12. Global Manufacturers of Cancer Spit Test Device, Manufacturing Sites & Headquarters
Table 13. Global Manufacturers of Cancer Spit Test Device, Product Type & Application
Table 14. Global Cancer Spit Test Device Manufacturers Established Date
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Cancer Spit Test Device by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 18. Thermo Fisher Scientific Company Information
Table 19. Thermo Fisher Scientific Business Overview
Table 20. Thermo Fisher Scientific Cancer Spit Test Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 21. Thermo Fisher Scientific Cancer Spit Test Device Product Portfolio
Table 22. Thermo Fisher Scientific Recent Developments
Table 23. Siemens Healthineers Company Information
Table 24. Siemens Healthineers Business Overview
Table 25. Siemens Healthineers Cancer Spit Test Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 26. Siemens Healthineers Cancer Spit Test Device Product Portfolio
Table 27. Siemens Healthineers Recent Developments
Table 28. Sarstedt Company Information
Table 29. Sarstedt Business Overview
Table 30. Sarstedt Cancer Spit Test Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 31. Sarstedt Cancer Spit Test Device Product Portfolio
Table 32. Sarstedt Recent Developments
Table 33. Salimetrics Company Information
Table 34. Salimetrics Business Overview
Table 35. Salimetrics Cancer Spit Test Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 36. Salimetrics Cancer Spit Test Device Product Portfolio
Table 37. Salimetrics Recent Developments
Table 38. Roche Holding AG Company Information
Table 39. Roche Holding AG Business Overview
Table 40. Roche Holding AG Cancer Spit Test Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 41. Roche Holding AG Cancer Spit Test Device Product Portfolio
Table 42. Roche Holding AG Recent Developments
Table 43. Qiagen Company Information
Table 44. Qiagen Business Overview
Table 45. Qiagen Cancer Spit Test Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 46. Qiagen Cancer Spit Test Device Product Portfolio
Table 47. Qiagen Recent Developments
Table 48. PeriRx Company Information
Table 49. PeriRx Business Overview
Table 50. PeriRx Cancer Spit Test Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 51. PeriRx Cancer Spit Test Device Product Portfolio
Table 52. PeriRx Recent Developments
Table 53. Oasis Diagnostics Corporation Company Information
Table 54. Oasis Diagnostics Corporation Business Overview
Table 55. Oasis Diagnostics Corporation Cancer Spit Test Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 56. Oasis Diagnostics Corporation Cancer Spit Test Device Product Portfolio
Table 57. Oasis Diagnostics Corporation Recent Developments
Table 58. Miraclean Technology Co.,Ltd. Company Information
Table 59. Miraclean Technology Co.,Ltd. Business Overview
Table 60. Miraclean Technology Co.,Ltd. Cancer Spit Test Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 61. Miraclean Technology Co.,Ltd. Cancer Spit Test Device Product Portfolio
Table 62. Miraclean Technology Co.,Ltd. Recent Developments
Table 63. Illumina Company Information
Table 64. Illumina Business Overview
Table 65. Illumina Cancer Spit Test Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 66. Illumina Cancer Spit Test Device Product Portfolio
Table 67. Illumina Recent Developments
Table 68. DNA Genotek Inc. Company Information
Table 69. DNA Genotek Inc. Business Overview
Table 70. DNA Genotek Inc. Cancer Spit Test Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 71. DNA Genotek Inc. Cancer Spit Test Device Product Portfolio
Table 72. DNA Genotek Inc. Recent Developments
Table 73. Color Health Inc Company Information
Table 74. Color Health Inc Business Overview
Table 75. Color Health Inc Cancer Spit Test Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 76. Color Health Inc Cancer Spit Test Device Product Portfolio
Table 77. Color Health Inc Recent Developments
Table 78. Canvax Company Information
Table 79. Canvax Business Overview
Table 80. Canvax Cancer Spit Test Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 81. Canvax Cancer Spit Test Device Product Portfolio
Table 82. Canvax Recent Developments
Table 83. BioMerieux Company Information
Table 84. BioMerieux Business Overview
Table 85. BioMerieux Cancer Spit Test Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 86. BioMerieux Cancer Spit Test Device Product Portfolio
Table 87. BioMerieux Recent Developments
Table 88. Biocartis Group Company Information
Table 89. Biocartis Group Business Overview
Table 90. Biocartis Group Cancer Spit Test Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 91. Biocartis Group Cancer Spit Test Device Product Portfolio
Table 92. Biocartis Group Recent Developments
Table 93. BD Company Information
Table 94. BD Business Overview
Table 95. BD Cancer Spit Test Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 96. BD Cancer Spit Test Device Product Portfolio
Table 97. BD Recent Developments
Table 98. Agilent Technologies Company Information
Table 99. Agilent Technologies Business Overview
Table 100. Agilent Technologies Cancer Spit Test Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 101. Agilent Technologies Cancer Spit Test Device Product Portfolio
Table 102. Agilent Technologies Recent Developments
Table 103. Abbott Laboratories Company Information
Table 104. Abbott Laboratories Business Overview
Table 105. Abbott Laboratories Cancer Spit Test Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 106. Abbott Laboratories Cancer Spit Test Device Product Portfolio
Table 107. Abbott Laboratories Recent Developments
Table 108. Global Cancer Spit Test Device Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 109. Global Cancer Spit Test Device Sales by Region (2021-2026) & (k units)
Table 110. Global Cancer Spit Test Device Sales Market Share by Region (2021-2026)
Table 111. Global Cancer Spit Test Device Sales by Region (2027-2032) & (k units)
Table 112. Global Cancer Spit Test Device Sales Market Share by Region (2027-2032)
Table 113. Global Cancer Spit Test Device Revenue by Region (2021-2026) & (US$ Million)
Table 114. Global Cancer Spit Test Device Revenue Market Share by Region (2021-2026)
Table 115. Global Cancer Spit Test Device Revenue by Region (2027-2032) & (US$ Million)
Table 116. Global Cancer Spit Test Device Revenue Market Share by Region (2027-2032)
Table 117. North America Cancer Spit Test Device Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 118. North America Cancer Spit Test Device Sales by Country (2021-2026) & (k units)
Table 119. North America Cancer Spit Test Device Sales by Country (2027-2032) & (k units)
Table 120. North America Cancer Spit Test Device Revenue by Country (2021-2026) & (US$ Million)
Table 121. North America Cancer Spit Test Device Revenue by Country (2027-2032) & (US$ Million)
Table 122. Europe Cancer Spit Test Device Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 123. Europe Cancer Spit Test Device Sales by Country (2021-2026) & (k units)
Table 124. Europe Cancer Spit Test Device Sales by Country (2027-2032) & (k units)
Table 125. Europe Cancer Spit Test Device Revenue by Country (2021-2026) & (US$ Million)
Table 126. Europe Cancer Spit Test Device Revenue by Country (2027-2032) & (US$ Million)
Table 127. Asia Pacific Cancer Spit Test Device Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 128. Asia Pacific Cancer Spit Test Device Sales by Country (2021-2026) & (k units)
Table 129. Asia Pacific Cancer Spit Test Device Sales by Country (2027-2032) & (k units)
Table 130. Asia Pacific Cancer Spit Test Device Revenue by Country (2021-2026) & (US$ Million)
Table 131. Asia Pacific Cancer Spit Test Device Revenue by Country (2027-2032) & (US$ Million)
Table 132. South America Cancer Spit Test Device Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 133. South America Cancer Spit Test Device Sales by Country (2021-2026) & (k units)
Table 134. South America Cancer Spit Test Device Sales by Country (2027-2032) & (k units)
Table 135. South America Cancer Spit Test Device Revenue by Country (2021-2026) & (US$ Million)
Table 136. South America Cancer Spit Test Device Revenue by Country (2027-2032) & (US$ Million)
Table 137. Middle East and Africa Cancer Spit Test Device Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 138. Middle East and Africa Cancer Spit Test Device Sales by Country (2021-2026) & (k units)
Table 139. Middle East and Africa Cancer Spit Test Device Sales by Country (2027-2032) & (k units)
Table 140. Middle East and Africa Cancer Spit Test Device Revenue by Country (2021-2026) & (US$ Million)
Table 141. Middle East and Africa Cancer Spit Test Device Revenue by Country (2027-2032) & (US$ Million)
Table 142. Global Cancer Spit Test Device Sales by Type (2021-2026) & (k units)
Table 143. Global Cancer Spit Test Device Sales by Type (2027-2032) & (k units)
Table 144. Global Cancer Spit Test Device Sales Market Share by Type (2021-2026)
Table 145. Global Cancer Spit Test Device Sales Market Share by Type (2027-2032)
Table 146. Global Cancer Spit Test Device Revenue by Type (2021-2026) & (US$ Million)
Table 147. Global Cancer Spit Test Device Revenue by Type (2027-2032) & (US$ Million)
Table 148. Global Cancer Spit Test Device Revenue Market Share by Type (2021-2026)
Table 149. Global Cancer Spit Test Device Revenue Market Share by Type (2027-2032)
Table 150. Global Cancer Spit Test Device Price by Type (2021-2026) & (USD/unit)
Table 151. Global Cancer Spit Test Device Price by Type (2027-2032) & (USD/unit)
Table 152. Global Cancer Spit Test Device Sales by Application (2021-2026) & (k units)
Table 153. Global Cancer Spit Test Device Sales by Application (2027-2032) & (k units)
Table 154. Global Cancer Spit Test Device Sales Market Share by Application (2021-2026)
Table 155. Global Cancer Spit Test Device Sales Market Share by Application (2027-2032)
Table 156. Global Cancer Spit Test Device Revenue by Application (2021-2026) & (US$ Million)
Table 157. Global Cancer Spit Test Device Revenue by Application (2027-2032) & (US$ Million)
Table 158. Global Cancer Spit Test Device Revenue Market Share by Application (2021-2026)
Table 159. Global Cancer Spit Test Device Revenue Market Share by Application (2027-2032)
Table 160. Global Cancer Spit Test Device Price by Application (2021-2026) & (USD/unit)
Table 161. Global Cancer Spit Test Device Price by Application (2027-2032) & (USD/unit)
Table 162. Key Raw Materials
Table 163. Raw Materials Key Suppliers
Table 164. Cancer Spit Test Device Distributors List
Table 165. Cancer Spit Test Device Customers List
Table 166. Cancer Spit Test Device Industry Trends
Table 167. Cancer Spit Test Device Industry Drivers
Table 168. Cancer Spit Test Device Industry Restraints
Table 169. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Cancer Spit Test Device Product Image
Figure 5. Global Cancer Spit Test Device Revenue (US$ Million), 2021 VS 2025 VS 2032
Figure 6. Global Cancer Spit Test Device Market Size (2021-2032) & (US$ Million)
Figure 7. Global Cancer Spit Test Device Sales (2021-2032) & (k units)
Figure 8. Global Cancer Spit Test Device Average Price (USD/unit) & (2021-2032)
Figure 9. Passive Drool Collection Methods Product Image
Figure 10. Oral Swab Collection Methods Product Image
Figure 11. Cancer Research Institutes Product Image
Figure 12. Hospitals Product Image
Figure 13. Diagnostic Laboratories Product Image
Figure 14. Oncology Speciality Clinics Product Image
Figure 15. Others Product Image
Figure 16. Global Cancer Spit Test Device Revenue Share by Manufacturers in 2025
Figure 17. Global Manufacturers of Cancer Spit Test Device, Manufacturing Sites & Headquarters
Figure 18. Global Top 5 and 10 Cancer Spit Test Device Players Market Share by Revenue in 2025
Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 20. Global Cancer Spit Test Device Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Figure 21. Global Cancer Spit Test Device Sales by Region in 2025
Figure 22. Global Cancer Spit Test Device Revenue by Region in 2025
Figure 23. North America Cancer Spit Test Device Market Size by Country in 2025
Figure 24. North America Cancer Spit Test Device Sales Market Share by Country (2021-2032)
Figure 25. North America Cancer Spit Test Device Revenue Market Share by Country (2021-2032)
Figure 26. United States Cancer Spit Test Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 27. Canada Cancer Spit Test Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 28. Mexico Cancer Spit Test Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 29. Europe Cancer Spit Test Device Market Size by Country in 2025
Figure 30. Europe Cancer Spit Test Device Sales Market Share by Country (2021-2032)
Figure 31. Europe Cancer Spit Test Device Revenue Market Share by Country (2021-2032)
Figure 32. Germany Cancer Spit Test Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 33. France Cancer Spit Test Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 34. U.K. Cancer Spit Test Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 35. Italy Cancer Spit Test Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 36. Russia Cancer Spit Test Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 37. Spain Cancer Spit Test Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 38. Netherlands Cancer Spit Test Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 39. Switzerland Cancer Spit Test Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 40. Sweden Cancer Spit Test Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 41. Poland Cancer Spit Test Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 42. Asia Pacific Cancer Spit Test Device Market Size by Country in 2025
Figure 43. Asia Pacific Cancer Spit Test Device Sales Market Share by Country (2021-2032)
Figure 44. Asia Pacific Cancer Spit Test Device Revenue Market Share by Country (2021-2032)
Figure 45. China Cancer Spit Test Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 46. Japan Cancer Spit Test Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 47. South Korea Cancer Spit Test Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 48. India Cancer Spit Test Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 49. Australia Cancer Spit Test Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 50. Taiwan Cancer Spit Test Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 51. Southeast Asia Cancer Spit Test Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 52. Southeast Asia Cancer Spit Test Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 53. South America Cancer Spit Test Device Market Size by Country in 2025
Figure 54. South America Cancer Spit Test Device Sales Market Share by Country (2021-2032)
Figure 55. South America Cancer Spit Test Device Revenue Market Share by Country (2021-2032)
Figure 56. Brazil Cancer Spit Test Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 57. Argentina Cancer Spit Test Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 58. Chile Cancer Spit Test Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 59. Middle East and Africa Cancer Spit Test Device Market Size by Country in 2025
Figure 60. Middle East and Africa Cancer Spit Test Device Sales Market Share by Country (2021-2032)
Figure 61. Middle East and Africa Cancer Spit Test Device Revenue Market Share by Country (2021-2032)
Figure 62. Egypt Cancer Spit Test Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 63. South Africa Cancer Spit Test Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 64. Israel Cancer Spit Test Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 65. Türkiye Cancer Spit Test Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 66. GCC Countries Cancer Spit Test Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 67. Global Cancer Spit Test Device Sales Market Share by Type (2021-2032)
Figure 68. Global Cancer Spit Test Device Revenue Market Share by Type (2021-2032)
Figure 69. Global Cancer Spit Test Device Price (USD/unit) by Type (2021-2032)
Figure 70. Global Cancer Spit Test Device Sales Market Share by Application (2021-2032)
Figure 71. Global Cancer Spit Test Device Revenue Market Share by Application (2021-2032)
Figure 72. Global Cancer Spit Test Device Price (USD/unit) by Application (2021-2032)
Figure 73. Cancer Spit Test Device Value Chain
Figure 74. Cancer Spit Test Device Production Mode & Process
Figure 75. Direct Comparison with Distribution Share
Figure 76. Distributors Profiles
Figure 77. Cancer Spit Test Device Industry Opportunities and Challenges
提及公司
Thermo Fisher ScientificSiemens HealthineersSarstedtSalimetricsRoche Holding AGQiagenPeriRxOasis Diagnostics CorporationMiraclean Technology Co.,Ltd.IlluminaDNA Genotek Inc.Color Health IncCanvaxBioMerieuxBiocartis GroupBDAgilent TechnologiesAbbott Laboratories
量子訊息有限公司為 APO Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們